4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0001127602-13-023097
CIK 0000884731operating
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 5:49 PM ET
Size
4.6 KB
Accession
0001127602-13-023097
Insider Transaction Report
Form 4
Keane Raymond T
SVP General Counsel & CCO
Transactions
- Sale
Common Stock
2013-07-18$19.79/sh−8,000$158,286→ 62,096 total
Footnotes (1)
- [F1]These shares were sold to satisfy witholding tax requirements related to the vesting of performance stock units previously reported. These shares were sold pursuant to a 10b5-1 trading plan adopted by the reporting person in December 2012.
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 5:49 PM ET
- Size
- 4.6 KB